Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EBIT Growth

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) -34.0336.7893.14298.54-62.91

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is -34.03 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar2026-34.03
Mar202536.78
Mar202493.14
Mar2023298.54
Mar2022-62.91

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2026 -34.03
Negative
Mar2025 36.78
-60.51
Mar2024 93.14
-68.80
Mar2023 298.54
Positive
Mar2022 -62.91 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,668.3 Cr -1.2% -10.5% -3.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,236.0 Cr -1.8% -3.7% 17.2% Stock Analytics
DIVIS LABORATORIES ₹249,673.0 Cr 3.4% 10.1% 57.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹187,460.0 Cr 1.6% 0.8% 37.8% Stock Analytics
CIPLA ₹111,484.0 Cr -0.4% -5.6% -11.9% Stock Analytics
DR REDDYS LABORATORIES ₹95,220.3 Cr -1.1% -4.9% -9.9% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-1.2%

-10.5%

-3.2%

SENSEX

-1.6%

-4.2%

-7.2%


You may also like the below Video Courses